HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/1/R39    most recent 00564.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Van Guilder, G. P. Articles by DeSouza, C. A. Search for Related Content PubMed PubMed Citation Articles by Van Guilder, G. P. Articles by DeSouza, C. A.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Metabolic syndrome and endothelial fibrinolytic capacity in obese adults

¹Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder; and ²Department of Medicine, University of Colorado, Health Sciences Center, Denver; and ³Denver Health Medical Center, Denver, Colorado

Submitted 6 August 2007 ; accepted in final form 22 October 2007

The metabolic syndrome (MetS) often accompanies obesity and contributes to the increased risk of atherothrombotic events with increased body fatness. Indeed, the risks for coronary artery disease and acute vascular events are greater with obesity combined with MetS compared with obesity alone. Endothelial release of tissue-type plasminogen activator (t-PA) is a key defense mechanism against thrombosis and has been shown to be impaired with obesity. The aim of the present study was to determine whether the presence of MetS exacerbates endothelial fibrinolytic dysfunction in obese adults. Net endothelial release of t-PA was determined in vivo in response to intrabrachial infusions of bradykinin and sodium nitroprusside in 47 sedentary adults: 15 normal weight (age 57 ± 2 yr; body mass index 22.9 ± 0.5 kg/m²), 14 obese but otherwise healthy (55 ± 1 yr; 29.4 ± 0.3 kg/m²), and 18 obese with MetS (55 ± 2 yr; 32.3 ± 1 kg/m²). MetS was established according to National Cholesterol Education Program ATP III criteria. Net release of t-PA antigen to bradykinin was 50% lower (P < 0.01) in the obese (from 2.5 ± 1.9 to 37.1 ± 5.3 ng·100 ml tissue^–1·min^–1) and obese with MetS (from 0.4 ± 0.8 to 32.5 ± 3.8 ng·100 ml tissue^–1·min^–1) compared with normal-weight (from 0.9 ± 1.0 to 74.3 ± 8.1 ng·100 ml tissue^–1·min^–1) subjects. However, there were no significant differences in the capacity of the endothelium to release t-PA in the obese and obese with MetS adults. These results indicate that the presence of the MetS does not worsen the obesity-related endothelial fibrinolytic dysfunction.

endothelium; fibrinolysis